Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Hidradenitis Suppurativa
Interventions
BIOLOGICAL

Blood tests

"For patients, it will be performed:~* a collection of blood samples (3 tubes of 5 mL) according to the usual medical management, in order to search for cardiovascular comorbidities associated with HS,~* A collection of 3 EDTA tubes and 2 additional dry tubes of 5 mL each according to the needs of the study."

PROCEDURE

exeresis

"For patients, it will be performed:~\- 6 tissue samples from the total excision specimen: two samples from the acute inflammatory zone (nodule, abscess, fistula) of 1 cm3; two samples from the chronic lesion zone (scar) of 1 cm3 and two samples from the peri-lesion zone (in the margin) of 1 cm3 on fresh tissue."

PROCEDURE

abdominoplasty

"For the controls, 6 fresh skin samples of 1 cm3 each will be taken from the abdominoplasty operation:~* four in the center,~* two in the margin"

Trial Locations (2)

59020

Hôpital Saint Vincent-de-Paul, Service de Dermatologie-Vénéréologie, Lille

59462

Hôpital Saint Philibert - Service de Chirurgie Viscérale, Lomme

All Listed Sponsors
lead

Lille Catholic University

OTHER

NCT05208099 - Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy | Biotech Hunter | Biotech Hunter